Skip to content
Search

Latest Stories

BACK TO SCHOOL: Getting your pharmacy ready

As schools break for summer, Rishi Bhatia advises how community pharmacy teams can plan ahead to meet all of their back-to-school related challenges…

As families across the UK embark on the fun of the summer holidays, strategic community pharmacy teams should be planning ahead for back-to-school related challenges that will soon rear their heads.


By preparing a fully-formed offering, pharmacy teams can make sure that in the post pandemic world of 2022, they are providing their communities with as much support as possible, and having a full-service offering is a key part of that story.

Through the consistent provision of a broad range of health promotion interventions, pharmacy teams can address key back-to-school issues, like children and parental health, throughout the entire year- in turn improving the health and wellbeing of the local population.

As part of the Healthy Living Pharmacy (HLP) framework each pharmacy has a dedicated area for a health promotion zone and, as such, in the lead up to children returning to school, these areas should be used to promote key services that address issues such as colds, head lice, first aid and dental health.

Alongside promotional activity, pharmacy teams should help families make sure they have the necessary range of products that will prove useful as their children return to school. First aid kits, including anti-bacterial products, plasters, and pain relief medication should be on hand in case minor ailments occur on the playground.

Pharmacy teams should also make sure they have plenty of cold medication stocked, as the back-to-school season so often sees a rise in cold infections.

What’s more, with the sunny weather September can often bring, families should safeguard their little ones by ensuring they have sun cream and after-sun products on hand. Dental health is also an issue that is paramount in the back-to-school period, with pharmacy teams being able to recommend child-friendly toothbrush and toothpaste options.

For families taking a more holistic approach to health, community pharmacy teams can advise on vitamins and supplements that children can take – helping to boost their health and wellbeing in the all important busy period of the new school year.

In conjunction with products, community pharmacy’s ability to provide vaccinations, especially for chickenpox, which can see a spike throughout the back-to-school period, is a vital service for communities across the UK.

As a member of Numark, the UK’s largest community pharmacy member organisation, which is also in fact bigger than Boots, my pharmacy team benefits from being able to offer low-cost own brand alternatives for the back-to-school season – something which is instrumental as families struggle with the cost of- living crisis this year.

We also receive marketing support, whether that be in the form of Point of Sale (POS) materials or training on customer service tactics, helping our pharmacy teams confidently approach the topic of children’s health.

But, of course, in the post pandemic setting of 2022 the back-to-school category differs from other years, with the market having seen monumental shifts over the last three years.

Historically the return to school period sees a focus on colds, head lice and general children’s health conditions, however this year the emphasis is on sanitising and the importance of engaging children on hygiene related issues.

In a bid to ensure another Covid wave doesn’t rear its head, schools, families, and healthcare providers should be placing onus on the value of encouraging children to prioritise hygiene as they return to school.

With children washing their hands more often, there also comes a risk of an increase in skincare issues such as contact dermatitis, as children’s hands are set to more regularly come into contact with a wide and varied range of soaps. For children with sensitive skin, community pharmacy teams are well placed to support by signposting products and services.

The focus on Infection Prevention and Control (IPC) has importance outside of the parameters of Covid, too. With infections such as monkeypox on the rise, community pharmacy (as the third pillar of the NHS) needs to adhere to strict procedures and encourage IPC in the communities we serve.

For monkeypox, we know the main form of transmission is touch, as well as coughing and sneezing, indicating how IPC remains paramount this back-to school season. When planning for the back to-school period, community pharmacy teams should also keep in mind the locality of their pharmacy. Data shows that the health of young children has improved over the past 30 years, however, there remains to be substantial health inequalities within communities, which in turns begets further issues for children returning to school.

For example, children who are living in deprived areas are statistically more likely to have poor diets, leading to an increased number of obese children, and, when coupled with the potential for ill-managed diabetes, means that many children face poor health outcomes.

Additionally, data from the Royal College of Paediatrics and Child Health , showcases those children who live in deprived areas are also more prone to mental health issues. As a community-facing healthcare provider, pharmacy teams are ideally suited to spot health related issues in deprived areas and are well-equipped to host accessible one-to-one discussions with families who require additional support.

Whilst many will think that families’ primary focus as they return to school is worrying about uniforms and pencil cases, the above data highlights how, for many, the back-to-school period can bring forth a range of key health issues.

Against the backdrop of the cost-of-living crisis, it’s vital that community pharmacy seeks to pharmacy like never before through innovation and providing more efficient support to the wider community.

Ultimately, by really listening to our communities during this period, not only can we safeguard the health of children as they return to school, but we can consolidate the crucial role of pharmacy to the entire healthcare ecosystem.

(Rishi Bhatia is a Numark Pharmacy member and superintendent pharmacist at RB Healthcare Group.)

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less